Subscribe to weekly updates from Teneo
Global Newsletter & Insights Series
Teneo’s global Health and Social Care practice engages with clients across healthcare services (private, public and social care), health tech and the life sciences sectors. Given our longstanding relationship with the NHS, we also have a dedicated NHS practice.
Over the last 20 years, Teneo has supported corporate clients, providers, payors, investors, lenders and charities in addressing complex challenges. We merge sector expertise with specialist capabilities to offer advice across a wide range of areas, including growth strategy, due diligence and transaction support, clinical strategy design and care delivery, value creation and performance improvement and strategy implementation.
Well-functioning health and social care is the backbone of any modern society, with the fundamental role played by the sector thrust into the spotlight during the Covid-19 pandemic. The pandemic created an unprecedented set of challenges for operators and investors in the market while simultaneously reinforcing the vital role the sector plays in our daily lives. As we emerge from the pandemic, the long-term fundamentals of the market are solid with strong demand drivers in place across most sub-sectors. Nevertheless, companies and provider organizations across the healthcare landscape find themselves operating in an increasingly complex environment. Cost pressures and budgetary constraints, talent shortages and clinician burnout, regulatory and legislative policy uncertainty, the rise of consumerism, new environmental, social and governance (ESG) expectations and innovations in both medicine and technology have reset organizational priorities and demand new solutions.
Teneo has extensive experience in helping healthcare organizations navigate the current environment and respond to internal and external pressures to drive better financial, operational and health outcomes. Our network of Senior Advisors and close partnerships with experts across our Financial Advisory, Risk Advisory, People Advisory and Strategy & Communications business segments help augment and differentiate the solutions we bring forth to our clients. Working closely with our dedicated NHS Practice in the UK, we have a clear view on the NHS, procurement trends, criteria and national health policy, including what impact these have on the independent sector and what role they can play in supporting the delivery of NHS services.
Our capabilities are global; we leverage local teams across the U.S., the UK, continental Europe and the Middle East to serve the needs of healthcare companies across our key areas of focus.
H2 2024 UK Economic and Consumer Forecast
Section 1: Executive Summary UK economic growth, falling inflation and wage growth have resulted in the recovery of household finances above 2021 levels. However, structural services inflation and higher interest rates present risks to sustained further consumer spending growth. Section 2: The UK Economy Continues to Recover in… Read More
2024 UK Economic and Consumer Forecast
Section 01: Executive summary Falling inflation and upward wage pressure are resulting in household relief after two years of real wage decline. However, continued pressure from mortgage rates and debt accumulation means we expect consumer spending to remain suppressed. 1: Slow growth and recessionary pressure are causing the UK labour… Read More
2023 UK Economic and Consumer Outlook
The UK narrowly avoided recession in 2022, and the most recent forecasts suggest low/stagnant growth, with the UK ultimately avoiding a technical recession that appeared inevitable in November when the country was still reeling from the impact of the previous Government's "mini budget." While inflation is forecast to fall, we… Read More
Private Hospitals; Clinic-Based Service Providers; Diagnostics; Healthcare Staffing; Mental Health; Animal Health
Elderly Care; Adult Specialist Care; Children’s Services
Healthcare Software; Social Care Software; Health Data; Digital-First Providers
Pharmaceuticals; CRO/CDMOs; Biotech; Medical Devices
Teneo helps clients assess markets to identify underlying attractiveness and growth opportunities, considering both industry dynamics and strategic fit. We have experience analyzing market size, developing growth forecasts and assessing competitive positioning to develop strategic, evidence-based advice. We use a data-based approach to evaluate local market and competitive dynamics, segment demand and identify the right strategy and proposition development to maximize growth. We support the design of new service lines or products considering demand, competition, pricing and go-to-market options – and support companies in enacting these strategies to deliver growth.
Teneo worked with one of the UK’s largest elderly care home operators to develop a meaningful portfolio segmentation using a data-based tool that recognizes the competitive potential of individual and cohorts of homes and helped prioritize investments and plan activity to maximize return across the portfolio.
Teneo offers a full range of transaction support services – from an initial market attractiveness assessment to target identification and commercial due diligence across both buy and sell-side mandates. We have experience in M&A processes and refinancing across a breadth of end sectors, serving both private equity and corporate clients.
Our experience includes both sell-side (e.g., a vendor commercial due diligence project for a leading European diagnostics provider), buy-side (e.g., supporting the acquisition of various healthcare software providers by a large UK trade buyer) and carve-out support (e.g., supporting the carve-out and divestment process of part of the portfolio for a major private healthcare company).
Teneo helps clients assess, define and implement their clinical strategies, advising on topics related to care coordination, specialty mix, models of care, organizational design and governance and technology enablement. This support is based on a detailed assessment of market factors and developments, including demographics, relevant disease rates, recent clinical developments, current service offerings and performance and competitive positioning. We often work closely with our clients to also develop the roadmap to effectively execute these strategies.
Teneo supported a large, leading private hospital in the UK to develop a five-year growth strategy, covering specialty and channel mix, vertical integration opportunities and optimal geographic footprint. Teneo worked with the client to translate the agreed strategy into a delivery plan with clear timelines, stakeholders and KPIs to track progress.
Teneo helps clients drive improvements within their business, focusing on the most important performance levers to increase margins and efficiency. This includes working with investors and their portfolio companies to identify, plan and implement value creation opportunities for the business to maximize returns throughout the asset hold period. We deliver both revenue and cost optimization processes, including opportunities in pricing, new revenue models, workforce optimization and Target Operating Models, all focused on delivering above-average profit growth and long-term competitive differentiation.
Teneo supported one of Europe’s largest veterinary care provider groups to free up clinical capacity to optimize the workforce in its portfolio of vet clinics. This included identifying, assessing and prioritizing opportunities for more efficient ways of working to support the company in meeting growing demand despite the industry-wide shortage of vets and veterinary nurses, while maintaining a high-quality service.
Teneo provides hands-on support to clients seeking to implement their strategies quickly and effectively. We work collaboratively with our clients, flexibly adjusting our approach to ensure the successful delivery of key strategic initiatives. Our support is tailored to our clients’ needs and includes helping structure the strategy execution process and key initiatives, actively driving progress and providing additional firepower and capacity to ensure the program receives sufficient time and attention to progress quickly without disrupting day-to-day operations.
Teneo worked with one of the UK’s largest private hospital operators, providing strategic project management (PMO) support for the implementation of a new Radiology Information System and OrderComms system. This included standing-up a robust project governance structure and providing hands-on support to implement new processes and workflows, standardize artifacts and develop systems architecture design.
The UK private healthcare market has seen a rebound in 2021 and 2022 post-Covid-19, driven in part by a surge in self-pay patients. A record number of people are opting to pay for their treatment privately to avoid long wait times in the NHS and access the quality and expertise…
The demand drivers for assisted fertility services are strong in the UK and across western Europe, and are expected to continue to create sustained growth in demand. At the same time, pressure on publicly provided services is increasing, created by funding pressures across health commissioners and resource shortages in public…
Sir David Dalton discusses with Ed Matthews his views on the impact of COVID-19 on the NHS. A lot has been asked of the NHS – it has risen to the challenge of Phase 1 of the crisis and in so doing it has revealed fragilities; and yet so much…
